Typhoid Fever Vaccine Industry Global Overview: Market Size, Growth Insights and Forecast
Report ID : 1373589 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Typhoid Fever Vaccine Industry is categorized based on Type of Vaccine (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine) and Route of Administration (Injectable, Oral) and End User (Hospitals, Clinics, Pharmacies, Research Institutes) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Typhoid Fever Vaccine Industry, valued at $500 million in 2023, is anticipated to expand to $1.2 billion by 2033 at a CAGR of 9.2% from 2024 to 2033. This report covers different segments and offers an analysis of the substantial trends and factors affecting the market.
As the Global Health challenges persist, the Typhoid Fever Vaccine Market is now crucially positioned as an area of focus for addressing one of the world’s greatest enduring infectious diseases. Typhoid fever remains a public health issue of importance because of its attacks in developing countries where hygiene and sanitary conditions are often below the standard unlike the countries. There is a growing burden of typhoid and also of antibiotic resistant strains which makes it all the more important to devise proper vaccination policies for controlling the spread and also protecting the vulnerable groups.
The market for typhoid fever vaccines is diverse, containing both live attenuated and polysaccharide vaccines aimed at providing immunity and protection from the fever. There has been increasing activity in the vaccine development in the form of new technologies as well as the ongoing research. Stricter regulations in public health and also the policies supporting vaccination coverage will help to strengthen the market and present important prospects for the major stakeholders in the healthcare market.
It is essential for stakeholders to pay attention to competitive dynamics, policy matters, and geographical differences as we explore the details the Typhoid Fever Vaccine Market. There is a considerable amount of research into the workings of market businesses and their positive impact on the global attempts in tackling typhoid fever which improves healthcare on a worldwide scale.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Sanofi Pasteur, Merck & Co., GlaxoSmithKline, Pfizer Inc., Novartis AG, Serum Institute of India, Bharat Biotech, Zydus Cadila, Astellas Pharma, Biological E. Limited, Takeda Pharmaceutical Company |
| SEGMENTS COVERED |
By Type of Vaccine - Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine
By Route of Administration - Injectable, Oral
By End User - Hospitals, Clinics, Pharmacies, Research Institutes
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Typhoid Fever Vaccine Industry Dynamics
The Typhoid Fever Vaccine Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Typhoid Fever Vaccine Industry Segmentations
Market Breakup by Type of Vaccine
- Overview
- Live Attenuated Vaccine
- Inactivated Vaccine
- Recombinant Vaccine
Market Breakup by Route of Administration
Market Breakup by End User
- Overview
- Hospitals
- Clinics
- Pharmacies
- Research Institutes
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Typhoid Fever Vaccine Industry
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Sanofi Pasteur
- Merck & Co.
- GlaxoSmithKline
- Pfizer Inc.
- Novartis AG
- Serum Institute of India
- Bharat Biotech
- Zydus Cadila
- Astellas Pharma
- Biological E. Limited
- Takeda Pharmaceutical Company
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved